Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
10/2007
10/17/2007EP1844780A2 Derivatives of aryl-quinazoline/aryl-2-amino-phenyl methanone which promote the release of parathyroid hormone
10/17/2007EP1844766A2 Inhibitors against the production and release of inflammatory cytokines
10/17/2007EP1844023A1 Quinazoline derivatives for the treatment and prevention of diabetes and obesity
10/17/2007EP1844022A1 Quinazoline derivatives for inhibiting cancer cell growth and method for the preparation thereof
10/17/2007EP1844021A1 Crystalline forms of rosuvastatin calcium salt
10/17/2007EP1844004A1 Quinazoline derivates as antiviral agents
10/17/2007EP1843820A1 Multicyclic bis-amide mmp inhibitors
10/17/2007EP1218353B1 Quinazoline derivatives
10/17/2007CN101056866A 4-arylspirocycloalkyl-2-aminopyrimidine carboxamide KCNQ potassium channel modulators
10/17/2007CN101056865A Aminoquinazolines compounds
10/17/2007CN101056864A Method for preparing pyrimidine compound
10/17/2007CN101056863A Process for the production of pyrimidine-5-carboxylates
10/17/2007CN100343338C Yellow anionic disazo dyes
10/17/2007CN100343253C Tetrahydro-4h-pyrido[1,2-a]pyrimidines and related compounds useful as HIV integrase inhibitors
10/17/2007CN100343238C Quinazoline derivatives as antitumor agents
10/17/2007CN100343237C Amide derivative and medicine
10/17/2007CN100343236C [N-(2-pyrimidine oxy) benzylamino phenyl] sulfamine compound, and its preparing method and use
10/16/2007US7282608 Inhibitors of histone deacetylase
10/16/2007US7282512 Such as 1-benzylcyclobutyl (1S)-1-(oxo{[(1R)-1-phenylethyl]amino}acetyl)pentylcarbamate for treatment of osteoporosis
10/16/2007US7282504 Kinase inhibitors
10/16/2007US7282502 S,N-diarylsulfonamide derivatives; treating inflammatory diseases such as Celiac's disease, Crohn's disease or colitis; N-(2-Benzoyl-4-chloro-phenyl)-4-chloro-benzenesulfonamide; N-[4-Chloro-2-(pyridin-2-ylsulfanyl)-phenyl]-4-isopropyl-benzenesulfonamide
10/16/2007US7282501 Drugs for treatment of Syndrome X, diabetes, hypoglycemic agents, antilipemic agents, arteriosclerosis and cardiovascular agents
10/11/2007WO2007113557A1 Substituted quinazolines with anti-cancer activity
10/11/2007WO2007113256A1 Hiv inhibiting 5-(hydroxymethylene and aminomethylene) substituted pyrimidines
10/11/2007WO2007089335A3 Multicyclic amino acid derivatives and methods of their use
10/11/2007WO2006123165A3 Pyrimidine derivatives as hsp90 inhibitors
10/11/2007WO2000072801A3 Alpha v integrin receptor antagonists
10/11/2007US20070238875 Heterocyclic compounds
10/11/2007US20070238740 Nitrosated And Nitrosylated Cardiovascular Compounds, Compositions And Methods Of Use
10/11/2007CA2645959A1 Hiv inhibiting 5-(hydroxymethylene and aminomethylene) substituted pyrimidines
10/10/2007EP1841746A1 Substituted 2-amino-quinazolin-4-on compoundsfor use in the treatment of cns disorders, pain, stroke, addicition and epilepsy, their preparation and use as intermediates
10/10/2007EP1841745A2 Process for the manufacture of a precursor of vitamin b1
10/10/2007EP1756029B1 Novel compounds, the preparation and the use thereof for a regiospesific synthesis of perfluor(alkyl) group heterocycles
10/10/2007EP1442019B1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors
10/10/2007EP1232150B1 Urea derivatives as anti-inflammatory agents
10/10/2007CN101052630A Substituted heterocyclic compounds and uses thereof
10/10/2007CN100341873C Pyrido [2,3-d] pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents
10/09/2007US7279582 For example (2S, 3S, 5S)-2-(2,6-dimethylphenoxyacetyl)amino-3-hydroxy-5-(2S-(1-tetrahydro-pyrimid-2-onyl)-3-methyl butanoyl)amino-1,6-diphenylhexane; HIV therapy
10/09/2007US7279577 Reacting phenylguanidine, a phenylguanidine salt with acetylacetone to produce 2-anilino-4,6-dimethylpyrimidine, wherein the reaction is carried out in the presence of water
10/09/2007US7279576 Anti-cancer medicaments
10/09/2007US7279575 Such as 2-(2-aminopyrimidin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one hydrochloride; for treatment of cell proliferative disorders/cancer; kits
10/09/2007US7279493 cyanoiminopiperazines which inhibit vanilloid receptor 1 function in a cell
10/09/2007US7279485 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
10/09/2007US7279478 Cathepsin cysteine protease inhibitors
10/09/2007US7279475 Cytokine inhibitors, useful for treating diseases and pathological conditions involving inflammation such as chronic inflammatory disease; for example, 1-(2-methoxy-5-trifluoromethyl-phenyl)-3-{4-[6-methyl-2-(2-morpholin-4-yl-ethyl)-pyrimidin-4-yloxy]-naphthalen-1-yl}-urea
10/09/2007US7279474 example compound: [7-(2,4-dichlorophenyl)-2-methyl-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl]-(1-ethyl-propyl)amine; treatment of irritable bowel disease and inflammatory bowel disease; anxiety; depression
10/09/2007US7279470 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
10/09/2007US7279444 for controlling undesirable plants
10/09/2007CA2240205C Methods for improving the residual control of mites and prolonging the protection of plants from mite infestations
10/09/2007CA2145928C N-(2-amino-4,6-dichloropyrimidin-5-yl)formamide, and a process for its preparation
10/04/2007WO2007112347A1 Dipeptidyl peptidase inhibitors
10/04/2007WO2007110868A2 Heterocyclic compounds and uses thereof in the treatment of sexual disorders
10/04/2007WO2007110363A1 Novel guanidine derivatives and their medical use
10/04/2007WO2007072201A3 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
10/04/2007WO2007072163A3 Pyrimidine derivatives
10/04/2007WO2007049158A3 Ppar modulating biaromatic compounds
10/04/2007US20070232661 Hedgehog Pathway Antagonists
10/04/2007US20070232631 1-[4-(5-Bromopyrimidin-2-ylsulfanyl)phenyl]-3-(2-nitrobenzoyl)-urea; antiproliferative, water soluble compound with high bioavailability
10/04/2007US20070232628 Calcium receptor antagonists; 2-(2-hydroxy-phenyl)-3-(4-isopropyl-phenyl)-5,6,7,8-tetrahydro-3H-quinazolin-4-one; bone disorders; hypoparathyroidism, osteosarcoma, periodontal disease, fracture healing, osteoarthritis, rheumatoid arthritis, Paget's disease, humoral hypercalcemia, osteoporosis
10/04/2007US20070232627 Anti-viral compounds
10/04/2007US20070232622 Small molecule toll-like receptor (TLR) antagonists
10/04/2007US20070232621 Linear dicationic terphenyls and their aza analogues as antiparasitic agents
10/04/2007US20070232614 Therapeutic Agent for Nonviral Hepatitis
10/04/2007US20070232607 Quinazoline Derivatives as Erbb Receptor Tyrosine kinases
10/04/2007US20070232586 Hydrazino-Substituted Heterocyclic Nitrile Compounds and Use Thereof
10/04/2007CA2681639A1 Compounds and methods for treatment of disorders associated with er stress
10/04/2007CA2680789A1 Heterocyclic compounds and uses thereof in the treatment of sexual disorders
10/03/2007EP1840122A1 Aminopyrimidine compounds and their salts, process for preparation and pharmaceutical use thereof
10/03/2007EP1840121A1 Glycine derivative and use thereof
10/03/2007EP1838304A2 Heterocyclic aspartyl protease inhibitors
10/03/2007EP1709010B8 Method for producing 2-amino-4,6-dichloro-5-formamidopyrimidine
10/03/2007EP1599468B1 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
10/03/2007CN101048388A Quinazolinone derivatives and their use as B-Raf inhibitors
10/03/2007CN101048387A Process for the preparation of phenyl 2-pyrimidinyl ketones and their novel intermediates
10/03/2007CN101048386A 嘧啶衍生物 Pyrimidine derivatives
10/03/2007CN101048385A Process for production of 4-aminopyrimidines
10/03/2007CN101048384A Pyrimidine and quinoline potentiators of metabotropic glutamate receptors
10/03/2007CN101045710A 2-[2(pyrimidine-2-radical-oxygen)-phenyl]-1-methoxy group-methyl acrylate derivate and preparation method thereof
10/03/2007CN100340548C Novel arylheteroalkylamine derivatives
10/02/2007US7276726 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds
10/02/2007US7276510 Viricides; prevent reproduction of human T-Cell lymphocyte virus
10/02/2007US7276501 6-(4-substituted-anilino)pyrimidine derivatives, method for preparation thereof and antiviral pharmaceutical composition comprising the same
10/02/2007US7276248 Conjugate having a cleavable linkage for use in a liposome
10/02/2007CA2413424C Substituted bicyclic derivatives for the treatment of abnormal cell growth
10/02/2007CA2387357C Derivatives of pyrazolo[4,3-d]pyrimidin-7-ones which inhibit cyclic guanosine 3',5'-monophosphate phosphodiesterase
10/02/2007CA2289509C Novel compounds
10/02/2007CA2160912C 3-(het)arylcarboxylic acid derivatives, their preparation and intermediates for their preparation
10/02/2007CA2096407C Retroviral protease inhibitors
09/2007
09/27/2007WO2007109783A2 Substituted pyrimidine kinase inhibitors
09/27/2007WO2007109577A1 Alkylamine-substituted bicyclic aryl compounds useful as modulators of ppar
09/27/2007WO2007109175A1 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
09/27/2007WO2007108744A2 Novel quinazolines as 5-ht6 modulators
09/27/2007WO2007108743A2 Novel quinazolines as 5-ht6 modulators ii
09/27/2007WO2007085833A3 Pyrimidine derivatives
09/27/2007US20070225497 Chiral Tertiary Aminoalkylnaphthols
09/27/2007US20070225495 N4-(2,2-Dimethyl-3-oxo-4H-5-pyrid[1,4]oxazin-6-yl)-N2-(3-chloro-4-methoxyphenyl)-5-fluoro-2,4-pyrimidinediamine; signal transduction cascade inhibitor; Fc receptors for IgE (Fc epsilon RI) and IgG (Fc gamma RI) antagonist; autoimmune diseases, antiinflammatory agent; rheumatoid arthritis
09/27/2007US20070225329 Aryl aniline beta2 adrenergic receptor agonists
09/27/2007US20070225327 3-Methyl-2-[4'-(pyridin-3-ylmethoxymethyl)-biphenyl-4-sulfonylamino]-butyric acid; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis
09/27/2007US20070225321 2,4-pyrimidinediamine compounds and their uses
09/27/2007US20070225308 2-Amino Quinazoline Derivative
1 ... 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 ... 427